期刊文献+

肺癌特异性靶向小分子多肽在肺腺癌放射治疗中的实验研究 被引量:1

Experimental study of radiotargeting-therapy with small molecular polypeptide in nude mice bearing lung adenocarcinoma
收藏 分享 导出
摘要 在固相合成小分子肽的过程中完成酪氨酸与cNGQGEQc的连接,采用氯胺-T法进行^131Ⅰ标记,构建肺腺癌NCI-H1975细胞株荷瘤裸鼠模型,随机分成4组,分别为:^131Ⅰ-cNGQGEQc治疗组、^131Ⅰ-cNAQAEQc治疗组、^131ⅠI治疗组和生理盐水对照组,每组5只。尾静脉注射相应药物后,连续30天观测荷瘤裸鼠肿瘤移植物的大小,计算各组荷瘤裸鼠的肿瘤抑制率。研究结果表明:小分子多肽的^131Ⅰ标记率均大于90%,放化纯度均大于95%。^131Ⅰ-cNGQGEQc对肺腺癌NCI-H1975细胞移植瘤具有明显的抑制作用,治疗后第30天移植瘤肿瘤抑制率为60.93%。阴性多肽^131Ⅰ-cNAQAEQc治疗组的肿瘤抑制率为11.63%。^131Ⅰ治疗组的肿瘤抑制率为10.70%。实验结果表明,^131Ⅰ-cNGQGEQc对肺腺癌NCI-H1975细胞具有良好的亲和力及明显的靶向抑制作用,对非小细胞肺癌的靶向治疗具有潜在应用价值。 Background: Integrin signal transduction pathways provide an important basis for molecular targeting therapy of cancerin tumor growth, infiltration and transfer. Existing research data have shown that small molecular peptide labeled with radionuclide has good clinical application prospects, but the successful researches on lung cancer have not been reported so far. It is considered that the main reason is the lack of small molecule peptide for specific targeting lung cancer. Purpose: Based on the small molecular peptide cNGQGEQc for specifically identifying integrin or3 and [31 found previously, polypeptide cNGQGEQc is selected and radiolabelled with ^131Ⅰ. And the inhibitory effect of ^131Ⅰ-cNGQGEQc in nude mice bearing lung adenocarcinoma is observed. Methods: The coupling of cNGQGEQc and tyrosine was done in the processing of solid phase synthesis of small molecular peptide. Chloramine-T method was used for radiolabelling of cNGQGEQc with 1311. Twenty nude mice bearing NCI-H1975 were built and randomly divided into four groups with five mice in each group, including the group of ^131Ⅰ-cNGQGEQc, the group ofl31I-cNAQAEQc, the group of ^131Ⅰ and the saline control group. The general condition was observed in nude mice beating tumor after tail vein injection of corresponding drugs. And the tumor sizes after grafting were measured per 3 days in 30 days. The inhibitory rate of tumor in each group was calculated. Results: The labeling efficiencies of ^131Ⅰ-cNGQGEQc and 13aI-cNAQAEQc were greater than 90% with the radiochemical purity of more than 95%, and ^131Ⅰ-cNGQGEQc had obvious inhibitory effect for transplantation tumor in nude mice beating NCI-H1975 adenocarcinoma of lung. After a treatment for 30 days the tumor inhibitory rates were 60.93% for the group of ^131Ⅰ-cNGQGEQc, 11.63% for the group of ^131Ⅰ-cNAQAEQ and 10.70% for the group of ^131Ⅰ. Conclusion: ^131Ⅰ-cNGQGEQc has a good affinity and effective inhibit effect for the NCI-H 1975 lung adenocarcinoma. Integrin is a promisin
作者 李贵平 黄宝丹 杜丽 韩彦江 黄凯 刘峰 郑文莉 张辉 郭琳琅 LI Guiping HUANG Baodan DU Li HAN Yanjiang HUANG Kai LIU Feng ZHENG Wenli ZHANG Hui GUO Linlang 1(Nanfang Hospital, Southern Medical University, Guangzhou 510515, China) 2(Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China)
出处 《核技术》 CAS CSCD 北大核心 2013年第6期24-28,共5页 Nuclear Techniques
基金 广东省科技计划项目(20128031800391)和南方医院院长基金项目(20122008)资助
关键词 肺腺癌 放射治疗 肽类 碘放射性同位素 裸鼠 Lung adenocarcinoma, Radiotherapy, Peptides, Iodine radioisotopes, Mice nude
作者简介 李贵平,男,1962年出生,1999年于上海第二医科大学获博士学位,中国科学院上海应用物理研究所博士后,主任医师,从事分子影像学和肿瘤核医学的研究
  • 相关文献

参考文献8

二级参考文献60

共引文献21

同被引文献13

  • 1程登峰,尹端沚,王明伟,李谷才,周伟,汪勇先.N-琥珀酰亚胺4-[^18F]氟苯甲酸酯的合成[J].核技术,2006,29(12):917-920. 被引量:6
  • 2Gao S, Ma Q J, Cui Q, et al. A pilot study on 99mTc-3PRGD2 scintigraphy in diagnosis of brain glioma[J]. Nuclear Science and Techniques, 2013, 24(2): 020301. DOI: 10.13538/j.1001-8042/nst.24.020301. 被引量:1
  • 3Gao S, Ma Q J, Wen Q, et al. 99mTc-3P4-RGD2 radiotracers for SPECT/CT of esophageal tumor[J]. Nuclear Science and Techniques, 2013, 24(4): 040302. DOI: 10.13538/j. 1001-8042/nst.24.040302. 被引量:1
  • 4Okarvi S M. Recent developments in 99mTc-labelled peptide-based radiopharmaceuticals: an overview[J]. Nuclear Medicine Communications, 1999, 20:1093-1112. DOI: 10.1097/00006231-1999t2000-00002. 被引量:1
  • 5Blok D, Feitsma R I J, Vermeij P, et al. Peptide radiopharmaceuticals in nuclear medicine[J]. European Journal of Nuclear Medicine and Molecular Imaging, 1999, 26: 1511-1519. DOI: 10.1007/s002590050488. 被引量:1
  • 6Kwekkeboom D, Krenning E P, De J M. Peptide receptor imaging and therapy[J]. Journal of Nuclear Medicine, 2000, 41(10): 1704-1713. 被引量:1
  • 7Schottelius M, Wester H J. Molecular imaging targeting peptide receptors[J]. Methods, 2009, 48(2): 161-177. DOI 10.1016/j.ymeth. 2009.03.012. 被引量:1
  • 8Boerman O C, Oyen W J G, Corstens F H M. Radio-labeled receptor-binding peptides: a new class of radiopharmaceuticals[J]. Seminars in Nuclear Medicine, 2000, 30(3): 195-208. DOI: 10.1053/snuc.2000.7441. 被引量:1
  • 9Guhlke S, Wester H J, Bruns C, et al. (2@8F]Fluoropropionyl-(D)Phel)-octreotide, a potential radiopharmaceutical for quantitative somatostain receptor imaging with PET: synthesis, radiolabeling, in vitro validation and biodistribution in mice[J]. Nuclear Medicine and Biology, 1994, 21: 819-825. DOI: 10.1016/0969- 8051 (94)90161-9. 被引量:1
  • 10Okarvi S M. Recent progress in fluorine-18 labelled peptide radiopharmaceuticals[J]. European Journal of Nuclear Medicine and Molecular Imaging, 2001, 28:929-938. DOI: 10.1007/s002590100508. 被引量:1

引证文献1

投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈